<--- Back to Details
First PageDocument Content
Pharmacology / Patient safety / Compounding / Hospital pharmacy / American Society of Health-System Pharmacists / McGuff Companies / Pharmacist / Barrier isolator / United States Pharmacopeia / Pharmaceutical sciences / Pharmacy / Health
Date: 2006-09-16 16:02:00
Pharmacology
Patient safety
Compounding
Hospital pharmacy
American Society of Health-System Pharmacists
McGuff Companies
Pharmacist
Barrier isolator
United States Pharmacopeia
Pharmaceutical sciences
Pharmacy
Health

Add to Reading List

Source URL: www.ashp.org

Download Document from Source Website

File Size: 230,98 KB

Share Document on Facebook

Similar Documents

CONTRIBUTORS To this number of THE GLEANER, either through direct question or by reference to publications. Where no title is affixed to the name, the contributor is a pharmacist. BREWER, F. L., M.D. COLE, W. S., M.D. C

DocID: 1vrBM - View Document

CONTRIBUTORS To this number of THE GLEANER, either through direct question or by reference to publications. Where no title is affixed to the name, the contributor is a pharmacist. CARMICHAEL, T. H., M.D. CARRYER, J. W.,

DocID: 1vqAx - View Document

The role of a Pharmacist Advanced Clinical Practitioner (ACP) within OPAT Julie Wilkinson Principal Pharmacist for Infection South Warwickshire NHS Foundation

DocID: 1vdDj - View Document

This standing order authorizes any pharmacist practicing in the state of Missouri and licensed by the Missouri Board of Pharmacy to dispense or sell the following naloxone products to persons as directed below. Naloxone

DocID: 1uXi5 - View Document

ALABAMA STATE BOARD OF PHARMACY 111 Village Street Birmingham, AlabamaFAXNUCLEAR PHARMACY AND PHARMACIST CERTIFICATE APPLICATION 680-X-2-.20

DocID: 1uS0c - View Document